![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](dn6209contents.gif)
Acta Cryst. (2005). E61, o1193-o1195 [ doi:10.1107/S1600536805009487 ]
4'-(2-Butyl-4-chloro-5-formylimidazol-1-ylmethyl)biphenyl-2-carbonitrile
H. S. Yathirajan, B. Nagaraj, R. S. Narasegowda, P. Nagaraja and M. Bolte
Abstract: The title compound, C22H20ClN3O, (I), is used as an intermediate for the synthesis of the antihypertensive drug losartan. Bond lengths and angles are unexceptional. The crystal packing is stabilized by one C-H
O and one C-H
N contact. It is noteworthy that (I) is isomorphous with a closely related compound which differs in having a but-2-enyl chain instead of a butyl chain on the imidazole ring.
Online 31 March 2005
Copyright © International Union of Crystallography
IUCr Webmaster